ENAapplication/xmlftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR151/007/SRR1517807/SRR1517807_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR151/004/SRR1517814/SRR1517814_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR151/005/SRR1517815/SRR1517815_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR151/009/SRR1517809/SRR1517809_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR151/009/SRR1517809/SRR1517809_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR151/008/SRR1517808/SRR1517808_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR151/000/SRR1517810/SRR1517810_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR151/006/SRR1517816/SRR1517816_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR151/008/SRR1517808/SRR1517808_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR151/001/SRR1517811/SRR1517811_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR151/002/SRR1517812/SRR1517812_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR151/000/SRR1517810/SRR1517810_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR151/003/SRR1517813/SRR1517813_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR151/005/SRR1517815/SRR1517815_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR151/007/SRR1517807/SRR1517807_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR151/001/SRR1517811/SRR1517811_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR151/004/SRR1517814/SRR1517814_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR151/006/SRR1517816/SRR1517816_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR151/003/SRR1517813/SRR1517813_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR151/002/SRR1517812/SRR1517812_2.fastq.gzprimaryOK200GenomicsNeurosurgery, UCSFhttps://www.ebi.ac.uk/ena/browser/view/PRJNA255430Homo sapiensxref:PubMed:25401693ChIP-Seq analysis of a pediatric human diffuse intrinsic pontine glioma (DIPG) cell line SF8628, harboring the K27M mutation. Goal was to obtain quantitative estimates of K27me3 immunoprecipitation change between vehicle-treated SF8628 cells [dimethyl sulfoxide, (DMSO)] and SF8628 cells incubated with 6 mM GSKJ4 at 24 hours and 72 hours. Overall design: Three-condition experiment: 72 h GSKJ4-treated cells vs. 24 h GSKJ4-treated cells vs. DMSO-treated cells. Biological replicates: 1 cell line, each with 2 technical replicates per condition.ENAfalseHomo sapiensPharmacologic inhibition of histone demethylation as a therapy for pediatric brainstem glioma [ChIP-seq]2025-09-242014-07-20PRJNA255430GSE59496960625401693